Melt-extruded formulations of fenofibrate with various grades of hydrogenated phospholipid exhibit promising in-vitro biopharmaceutical behavior
European Journal of Pharmaceutical Sciences · 2024
DOI: 10.1016/j.ejps.2024.106936 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2024. Verfasst von Mikołaj Czajkowski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inorganic & Analytical Chemistry, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland…. Hauptthemen laut MEDLINE: Fenofibrate, Phospholipids, Hypolipidemic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Agency for Academic Exchange, Phospholipid Research Center.
Abstract (Originalsprache)
In the current study, it was demonstrated that three commercially available grades of hydrogenated phospholipids (HPL) differing in their content of phosphatidylcholine may be used as components for hot melt-extruded binary (HPL as sole excipient) or ternary (in combination with copovidone) solid dispersions of fenofibrate (FEN) at mass fractions between 0.5 and 20% (ternary) or 80% (binary). X-ray powder diffraction indicated complete conversion of crystalline fenofibrate into the amorphous state by hot melt extrusion for all ternary blends. In contrast, both the binary blends (HPL- and copovidone-based) contained minor remaining crystallites. Irrespectively, all solid dispersions induced during dissolution studies a supersaturated state of FEN, where the ternary ASDs showed enhanced and more complete release of FEN as compared to the binary blends and, even more pronounced, in comparison to the marketed micronized and nano-milled formulations. In terms of the cumulated amount permeated, there were marginal differences between the various formulations when combined dissolution/permeation was done using FeSSIF as donor medium; with FaSSIF as donor medium, the binary HPL-ASD containing the grade with the highest phosphatidylcholine fraction performed best in terms of permeation, even significantly better than the marketed nano-crystal formulation. Otherwise, no significant differences were seen between the various grades of HPL when FEN dissolution and permeation were analyzed for ternary solid dispersions. In conclusion, the in-vitro biopharmaceutical behaviour of hydrogenated phospholipid-containing blends manufactured by hot melt extrusion appears promising. They can be a viable formulation option for poorly water-soluble and lipophilic drug compounds like FEN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Inorganic & Analytical Chemistry, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland; Department of Physics, Chemistry and Pharmacy, University of Souther…
- Chair and Department of Pharmaceutical Technology, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland; GENERICA Pharmaceutical Lab, Regionalne Centrum Zdrowia Sp. z o.o…
- Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, Odense 5230, Denmark.
- Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, Odense 5230, Denmark. Electronic address: mmb@sdu.dk.
- Department of Inorganic & Analytical Chemistry, Collegium Pharmaceuticum, Poznan University of Medical Sciences, Rokietnicka 3, Poznan 60-806, Poland.
Förderung
- National Agency for Academic Exchange
- Phospholipid Research Center
Zitieren
APA
Czajkowski, M., Słaba, A., Milanowski, B., Bauer-Brandl, A., Brandl, M., & Skupin-Mrugalska, P. (2024). Melt-extruded formulations of fenofibrate with various grades of hydrogenated phospholipid exhibit promising in-vitro biopharmaceutical behavior. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2024.106936
Vancouver
Czajkowski M, Słaba A, Milanowski B, Bauer-Brandl A, Brandl M, Skupin-Mrugalska P. Melt-extruded formulations of fenofibrate with various grades of hydrogenated phospholipid exhibit promising in-vitro biopharmaceutical behavior. European Journal of Pharmaceutical Sciences. 2024. doi:10.1016/j.ejps.2024.106936
BibTeX
@article{Czajkowski2024,
author = {Czajkowski, Mikołaj and Słaba, Aleksandra and Milanowski, Bartłomiej and Bauer-Brandl, Annette and Brandl, Martin and Skupin-Mrugalska, Paulina},
title = {Melt-extruded formulations of fenofibrate with various grades of hydrogenated phospholipid exhibit promising in-vitro biopharmaceutical behavior},
journal = {European Journal of Pharmaceutical Sciences},
year = {2024},
doi = {10.1016/j.ejps.2024.106936}
}
EUVIMED